![Emily Arsenault](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Emily Arsenault first degree
Entity | Entity type | Industry | |
---|---|---|---|
Plexium, Inc.
![]() Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Emily Arsenault via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Cajal Neuroscience, Inc.
![]() Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Biotechnology | Director/Board Member Director/Board Member Founder | |
The Column Group LLC
![]() The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Kallyope, Inc.
![]() Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Lux Capital Group LLC
![]() Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California. | Investment Managers | Private Equity Analyst Consultant / Advisor | |
Pivotal Bioventure Partners Investment Advisor LLC
![]() Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Analyst | |
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Illinois | College/University | Doctorate Degree | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ambys Medicines, Inc.
![]() Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Bioniz Therapeutics, Inc.
![]() Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Univercells SA
![]() Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Biotechnology | Director/Board Member | |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
BioMotiv LLC
![]() BioMotiv LLC BiotechnologyHealth Technology BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
OrphoMed, Inc.
![]() OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | Pharmaceuticals: Major | Director/Board Member | |
Evommune, Inc.
![]() Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
G.D. Searle LLC | Corporate Officer/Principal | ||
MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal | |
TargeGen, Inc.
![]() TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree | |
Kimia Therapeutics, Inc.
![]() Kimia Therapeutics, Inc. BiotechnologyHealth Technology Kimia Therapeutics, Inc. is a drug discovery company that utilizes high throughput precision chemistry, genome editing, and machine learning to identify druggable sites for human disease intervention. The private company is based in Berkeley, CA. The company is building a next-generation therapeutics discovery platform called Atlas, which combines active learning with automated synthesis and screening. Atlas is powered by a high-throughput, nano-liter scale chemistry platform that provides Kimia with instant access to billions of drug-like compounds. The CEO of the company is Stig K. Hansen. | Biotechnology | Founder | |
InduPro, Inc.
![]() InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Biotechnology | Director/Board Member | |
Abintus Bio, Inc.
![]() Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Miscellaneous Commercial Services | Director/Board Member | |
SURROZEN, INC. | Biotechnology | Director/Board Member | |
Nura Bio, Inc.
![]() Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder | |
Synthekine, Inc.
![]() Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
Surrozen Operating, Inc.
![]() Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer | |
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Chairman | |
RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Neurona Therapeutics, Inc.
![]() Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Biotechnology | Chairman | |
University of California, Berkeley | College/University | Doctorate Degree | |
NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
St. Louis University | College/University | Graduate Degree | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Rallybio Holdings LLC
![]() Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
Rivet Health, Inc.
![]() Rivet Health, Inc. Packaged SoftwareTechnology Services Rivet Health, Inc. designs and develops a software application which organizes, analyzes, and optimizes payer reimbursement contracts and fee schedules. The firm offers Rivet application. The company was founded by Paul Draper, Andrew Harding, and Edward Ferrin and is headquartered in Holladay, UT. | Packaged Software | Director/Board Member | |
Dimension Management LP
![]() Dimension Management LP Investment ManagersFinance Dimension Management LP is based in New York, NY. Dimension Management LP is a company that partners with founders at the intersection of technology and life sciences. The company was founded by Adam Goulburn, Zavain Dar, Nan Li. | Investment Managers | Founder | |
Aquilo Capital Management LLC
![]() Aquilo Capital Management LLC Investment ManagersFinance Aquilo Capital Management LLC (Aquilo) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. Aquilo was founded in 2010 to manage investment funds and separately managed accounts for individual clients. | Investment Managers | Analyst-Equity | |
Swarthmore College | College/University | Undergraduate Degree | |
TCG Crossover Management LLC
![]() TCG Crossover Management LLC Investment ManagersFinance TCG Crossover Management LLC (TCG Crossover Management) is a venture capital firm founded in 2021 by Chen-Ming Yu. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Tourmaline Bio, Inc.
![]() Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Director/Board Member | |
Yale University | College/University | Undergraduate Degree | |
Careguardian, Inc.
![]() Careguardian, Inc. Medical/Nursing ServicesHealth Services Careguardian, Inc. provides health care services. The firm transforms the in-home care and aging experience by providing clients with personalized care planning, expert caregiver matching, custom mobile technology, and proactive case management to improve older adults’ health and well-being while giving its families peace of mind. The company was founded by Josh Bruno and Akash Shah in 2013 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
HotSpot Therapeutics, Inc.
![]() HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member |
Statistics
International
United States | 48 |
Japan | 2 |
Belgium | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 6 |
Health Services | 4 |
Operational
Director/Board Member | 100 |
Corporate Officer/Principal | 20 |
Independent Dir/Board Member | 18 |
Chairman | 15 |
Chief Executive Officer | 14 |
Most connected contacts
Insiders | |
---|---|
Michael Grey | 32 |
Joey Mason | 31 |
Robert Hopfner | 20 |
Adam Goulburn | 20 |
Timothy Kutzkey | 18 |
Michael Martin | 17 |
Brian Wong | 9 |
Ming Cheah | 9 |
Cariad Chester | 7 |
Ian Peikon | 5 |
- Stock Market
- Insiders
- Emily Arsenault
- Company connections